George E Laramore
Overview
Explore the profile of George E Laramore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
961
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takayesu J, Parvathaneni U, Laramore G, Panjwani N, Sillings J, Futran N, et al.
Cancer Rep (Hoboken)
. 2025 Feb;
8(2):e70111.
PMID: 39907094
Background: Head and neck mucosal melanoma (HNMM) is rare and carries a poor prognosis with high rates of disease progression. There is little data regarding the use of adjuvant proton...
2.
Pan C, Ng K, Voutsinas J, Barber B, Rizvi Z, Marchiano E, et al.
BMC Cancer
. 2024 Nov;
24(1):1406.
PMID: 39543541
Background: We previously reported in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs), pretreatment higher lactate dehydrogenase (LDH) and absolute (abx) neutrophils as...
3.
Moffitt G, Sandison G, Argento D, Emery R, Wootton L, Parvathaneni U, et al.
Phys Med Biol
. 2023 Nov;
68(24).
PMID: 37983905
Fast neutron therapy is a high linear energy transfer (LET) radiation treatment modality offering advantages over low LET radiations. Multileaf collimator technology reduces normal-tissue dose (toxicity) and makes neutron therapy...
4.
Mumaw D, Hazy A, Vayntraub A, Quinn T, Salari K, Chang J, et al.
Radiother Oncol
. 2023 Nov;
190:109977.
PMID: 37922991
Introduction: Unilateral radiation therapy is appropriate for select patients with oropharyngeal squamous cell carcinoma (OPSCC). The use of proton beam therapy (PBT) in the unilateral setting decreases the dose to...
5.
Gobillot T, Greer M, Parvathaneni U, Liao J, Laramore G, Goff P, et al.
Head Neck
. 2023 Jul;
45(9):2323-2334.
PMID: 37448346
Background: Perineural invasion (PNI) in head and neck squamous cell carcinoma (HNSCC) portends poor prognosis. Extent of treatment of nerve pathways with varying degrees of PNI and patterns of failure...
6.
Pan C, Wu Q, Voutsinas J, Houlton J, Barber B, Rizvi Z, et al.
Cancer Med
. 2023 Feb;
12(8):9384-9391.
PMID: 36806947
Background: Little is known regarding associations between peripheral blood biomarkers (PBBMs) and survival, response, and toxicity in recurrent/metastatic head and neck squamous cell carcinomas (R/M HNSCC) treated with immune checkpoint...
7.
Pan C, Wu Q, Voutsinas J, Houlton J, Barber B, Futran N, et al.
Head Neck
. 2022 Nov;
45(2):391-397.
PMID: 36412064
Background: Associations between peripheral blood biomarkers and oncologic outcomes were explored in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HN) and salivary gland cancer (SGC) treated with pembrolizumab and...
8.
Chalker C, Voutsinas J, Wu Q, Santana-Davila R, Hwang V, Baik C, et al.
Cancer Med
. 2022 Mar;
11(22):4104-4111.
PMID: 35349227
Background: Anti-PD1 checkpoint inhibitors (ICI) represent an established standard-of-care for patients with recurrent/metastatic head and neck squamous cell carcinoma (RMHNSCC). Landmark studies excluded patients with ECOG performance status (PS) ≥2;...
9.
Chalker C, Santana-Davila R, Voutsinas J, Wu Q, Hwang V, Baik C, et al.
J Palliat Med
. 2021 Dec;
25(4):614-619.
PMID: 34847733
End-of-life health care utilization (EOLHCU) is largely uncharacterized among patients with recurrent/metastatic head and neck squamous cell carcinomas (RMHNSCC), particularly now that immune checkpoint inhibitors (ICI) have been introduced to...
10.
Viscariello N, Greer M, Parvathaneni U, Liao J, Laramore G, Stewart R
Int J Part Ther
. 2021 Nov;
8(2):51-61.
PMID: 34722811
Purpose: Neutron therapy is a high linear energy transfer modality that is useful for the treatment of radioresistant head and neck (H&N) cancers. It has been limited to 3-dimensioanal conformal-based...